Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 12 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Canadian patent secured for PromarkerEso test for EAC
- Appointment of CEO and Managing Director
- Proteomics US lab CAP accredited - extends precision Dx lab
- US patent secured for PromarkerEso diagnostic test for EAC
- PromarkerD predicts risk of DKD in Aboriginal Australians
Later from Proteomics International Laboratories
- Appendix 4D and Interim Financial Report
- Restructure, Executive Appointment and Board Update
- Proteomics Strategic Plan
- US patent secured for PromarkerEndo
- Proteomics signs national distribution deal with Healius
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories